New bacterial vaginosis treatment aims to rebalance vaginal flora
NCT ID NCT07481955
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times
Summary
This study tests a new treatment called FB301 in 120 women aged 18-45 with bacterial vaginosis (BV). Before FB301, some women will receive an antibiotic or a vaginal wash to see if that helps restore healthy bacteria. The goal is to improve the balance of good bacteria in the vagina over 10 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL VAGINOSIS (BV) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CRS Clinical Research Services Berlin GmbH
RECRUITINGBerlin, State of Berlin, 13627, Germany
-
CRS Clinical Research Services Mannheim
RECRUITINGMannheim, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.